EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/06/2025
Voltar para busca
Dado oficial do USPTO
272BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
11/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42
Data de depósito
13/04/2021
Data de registro
01/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2022
Última transação
11/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
GB
Examinador
LAVACHE, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
272BIO Limited
Representantes
Robert S. Broder Collard & Roe, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Veterinary preparations for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; medical preparations for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; pharmaceutical preparations for veterinary and/or medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; biological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; biotechnological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; medicinesantibody therapeutic preparations and veterinary vaccines for livestock; biotherapeutic medicines for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals
Classe 40
Custom manufacture of veterinary preparations and medical preparations; custom manufacture of pharmaceutical preparations for veterinary and medical use; custom manufacture of biological preparations for veterinary and medical use; custom manufacture of biotechnological preparations for veterinary and medical use; custom manufacture of medicines including biotherapeutic medicines
Classe 42
Scientific research and development; biotechnological research and development; biotechnological research and development relating to animals and livestock; biotherapeutic product development; medical and veterinary laboratory services; clinical research in the field of veterinary preparationsbiotherapeutic medicinesantibodies; conducting clinical trials for others; informationadvice and consultancy relating to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2023
FIMP
FINAL DISPOSITION PROCESSED
22/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
23/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2022
PUBO
PUBLISHED FOR OPPOSITION
16/08/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
14/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
14/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/06/2022
RFNT
REFUSAL PROCESSED BY IB
23/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/01/2022
RFRR
REFUSAL PROCESSED BY MPU
06/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/12/2021
CNRT
NON-FINAL ACTION WRITTEN
08/12/2021
DOCK
ASSIGNED TO EXAMINER
04/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 272BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.